Amendment: SEC Form SCHEDULE 13G/A filed by Compugen Ltd.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 1)
|
COMPUGEN LTD (Name of Issuer) |
Ordinary Shares, par value NIS 0.01 (Title of Class of Securities) |
M25722105 (CUSIP Number) |
12/31/2024 (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
![]() |
![]() |
![]() |
SCHEDULE 13G
|
CUSIP No. | M25722105 |
1 | Names of Reporting Persons
BRISTOL MYERS SQUIBB CO | ||||||||
2 | Check the appropriate box if a member of a Group (see instructions)
![]() ![]() | ||||||||
3 | Sec Use Only | ||||||||
4 | Citizenship or Place of Organization
DELAWARE
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
9 | Aggregate Amount Beneficially Owned by Each Reporting Person
1,840,136.00 | ||||||||
10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
![]() | ||||||||
11 | Percent of class represented by amount in row (9)
2.06 % | ||||||||
12 | Type of Reporting Person (See Instructions)
CO |
SCHEDULE 13G
|
Item 1. | ||
(a) | Name of issuer:
COMPUGEN LTD | |
(b) | Address of issuer's principal executive offices:
26 Harokmim Street, Holon, Israel, 8558549 | |
Item 2. | ||
(a) | Name of person filing:
Bristol-Myers Squibb Company | |
(b) | Address or principal business office or, if none, residence:
Route 206 & Province Line Road
Princeton, NJ 08543 | |
(c) | Citizenship:
Delaware | |
(d) | Title of class of securities:
Ordinary Shares, par value NIS 0.01 | |
(e) | CUSIP No.:
M25722105 | |
Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
(a) | ![]() | |
(b) | ![]() | |
(c) | ![]() | |
(d) | ![]() | |
(e) | ![]() | |
(f) | ![]() | |
(g) | ![]() | |
(h) | ![]() | |
(i) | ![]() | |
(j) | ![]() please specify the type of institution: | |
(k) | ![]() | |
Item 4. | Ownership | |
(a) | Amount beneficially owned:
See response to Item 9 on the cover page. | |
(b) | Percent of class:
See response to Item 11 on the cover page. | |
(c) | Number of shares as to which the person has:
| |
(i) Sole power to vote or to direct the vote:
See response to Item 5 on the cover page. | ||
(ii) Shared power to vote or to direct the vote:
See response to Item 6 on the cover page. | ||
(iii) Sole power to dispose or to direct the disposition of:
See response to Item 7 on the cover page. | ||
(iv) Shared power to dispose or to direct the disposition of:
See response to Item 8 on the cover page. | ||
Item 5. | Ownership of 5 Percent or Less of a Class. | |
![]() | ||
Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
Item 9. | Notice of Dissolution of Group. | |
Not Applicable
|
Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|